The fruit and vegetable juices maker will find new distribution channels, and expand its innovation pipeline following the investment, said Coldpress’ founder Andrew Gibb.
“The welcome approach of Odexia and Marechale underpins the significant and sustainable success our vibrant drinks business has enjoyed both at home and abroad in recent months,” Gibb said.
“We feel now is the perfect moment to forge ahead, expand our sales and marketing function, accelerate our unrivalled innovation pipeline and open up other influential distribution channels both at home and abroad.”
Healthier-living market
Investment firm Odexia said Coldpress successfully tapped into today’s growing healthier-living market.
The firm’s co-founder Carl Atkinson said: “Odexia were especially encouraged by Coldpress’ robust financials, that are all too rare among ambitious, modern-day growth companies.
“It’s a well-managed operation that sits comfortably amongst our growing family of opinion-forming disruptor brands.”
Marechale Capital – a joint venture partner with Odexia’s Consumer Brand Fund – also provided investment for Coldpress.
‘A dynamic and innovative brand’
“Coldpress is the dominant brand in the European cold-pressed juice market, and we’re pleased to have provided our investor clients which such a dynamic and innovative brand investment,” said Marechale Capital ceo Patrick Booth-Clibborn.
“At Marechale we are fortunate to have advised and financed some of the UK's leading consumer and leisure brands, and we are delighted to have backed Gibb, one the leading voices within the cold-pressed drinks sector, and his dynamic team.”
Coldpress makes smoothies, vegetable juices, almond drinks, fruit juice-flavoured coconut water, and low-calorie soft drinks. The manufacturer said it wanted to remind consumers that lowering their sugar intake did not mean sacrificing essential daily nutritional intake.
The juice maker supplies supermarkets Tesco and Waitrose, as well as Boots, Carrefour and Autogrill.
Coldpress Foods investment – at a glance
- Cash injection from Odexia and Marechale Capital
- Increase sales and marketing
- Increase product innovation
- Enter new markets